- Datum02.07.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Altan Cantürk
Moderator
Insmed Inc. Aktie
Verkaufen
Kaufen
Insmed Inc. Chart
Echtzeit-News zu diesem und anderen Unternehmen findest Du hier!
Live-Ticker Insmed Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-3,00 %
Intraday
-7,82 %
1 Woche
40,00 %
1 Monat
41,40 %
Seit Jahresbeginn
47,15 %
1 Jahr
367,30 %
3 Jahre
234,43 %
5 Jahre
308,79 %
10 Jahre
Passender Service zu Insmed Inc.
Webinar zu Insmed Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)60,400-106,830
- Jahrestief / Hoch ($)60,400-106,830
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Insmed Inc.
Keine Dividenden verfügbar
Termine von Insmed Inc.
- Jul31Insmed Inc.Q2 2025 Earnings Release
- Okt23Insmed Inc.Q3 2025 Earnings Release
- Feb19Insmed Inc.Q4 2025 Earnings Release
Beschreibung
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
